• The Role of Biosimilars Suzanne Elvidge
    February 12, 2025
    Biological drugs are therapeutics that are made by living organisms or are created from cells and tissues, and include therapeutic proteins and monoclonal antibodies.
  • The Value of Streamlining Manufacturing Suzanne Elvidge
    February 12, 2025
    Drug manufacturing makes up a significant part of what it costs to develop drugs. As expenditures for ingredients, power, equipment, rent and staff increase, companies are working hard to find ways to cut outlays through streamlining.
  • Improving the patient experience: Developing patient-centric dosage forms Suzanne Elvidge
    February 05, 2025
    Medication non - adherence impacts many. Patient - centric drug design via simplifying dose, ease - of - taking, better packaging, and 3D - printing can boost adherence.
  • How AI Can Drive Drug Discovery Suzanne Elvidge
    November 27, 2024
    The use of artificial intelligence (AI) is growing, from banking and biodiversity to travel and transport. One of the areas where its presence is significant is healthcare.
  • Making Cell and Gene Therapy Affordable Suzanne Elvidge
    November 04, 2024
    Cell and gene therapies (CGTs) have revolutionised medicine, providing personalised and targeted treatment for life-limiting diseases from genetic disorders to hard-to-treat cance.However, these cutting-edge therapeutics can come with a high price tag.
  • How to Find and Select the Right Products and Partners Suzanne Elvidge
    October 15, 2024
    Working in partnership, is a powerful way to boost pipelines and support preclinical and clinical research and development.The challenge is finding the right partner and the right product or project.
  • Hints and Tips for Negotiating and Managing National and International Deals Suzanne Elvidge
    October 15, 2024
    Once a company has made the decision to partner or collaborate and has found the right product or the right partner – the next step is to create a strong relationship and negotiate the best possible deal for both parties.
  • Working Collaboratively: Using Co-operation to Boost Pipelines Suzanne Elvidge
    September 26, 2024
    As drugs, devices and other healthcare products become more innovative and complex, and as development costs increase, working collaboratively becomes more important.
  • The Importance of Patient-Centricity in Drug Development Suzanne Elvidge
    August 29, 2024
    Patient centricity can be defined as: ‘Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family.
  • Immunoconjugates: Biological Missiles for Diagnosis and Treatment Suzanne Elvidge
    August 02, 2024
    Immunoconjugates already play an important role in the treatment of cancer, and their role is likely to expand into other therapeutic indications.
PharmaSources Customer Service